Prognostic difference between early breast cancer patients with HER2 low and HER2 zero status
Abstract We aimed to investigate the differences in prognosis between patients with HER2-low and HER2-zero status. This retrospective cohort study conducted at multi-institution included 1627 patients diagnosed with HER2-low or HER2-zero breast cancer (stages I–III). Survival analysis after propensi...
Saved in:
| Main Authors: | Chihwan David Cha, Kyung Eun Kim, Jungbin Kim, Eunhae Um, Nayeon Choi, Jungsun Lee, Geumhee Gwak, Jae Il Kim, Min Sung Chung |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-03-01
|
| Series: | npj Breast Cancer |
| Online Access: | https://doi.org/10.1038/s41523-025-00737-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Subtype-specific prognostic impact of Bcl-2 in HER2-positive and HER2-negative breast cancer
by: Taeyeong Kim, et al.
Published: (2025-01-01) -
Correction: Differentiating HER2-low and HER2-zero tumors with 21-gene multigene assay in 2,295 HR + HER2- breast cancer: a retrospective analysis
by: Yoonwon Kook, et al.
Published: (2024-11-01) -
The frequency and clinical impact of HER2 alterations in lung adenocarcinoma.
by: Eun Kyung Kim, et al.
Published: (2017-01-01) -
CKAP2 (cytoskeleton-associated protein2) is a new prognostic marker in HER2-negative luminal type breast cancer.
by: Sung Hoon Sim, et al.
Published: (2017-01-01) -
Clinical Outcomes of CDK4/6 Inhibitor Therapy in HR+/HER2− Metastatic Breast Cancer: A Multicenter Comparison of HER2-Low and HER2-Zero Subgroups
by: Erkan Ozcan, et al.
Published: (2025-01-01)